Literature DB >> 8155646

Selective activation of inhibitory G-protein alpha-subunits by partial agonists of the human 5-HT1A receptor.

T W Gettys1, T A Fields, J R Raymond.   

Abstract

Plasma membranes from Chinese hamster ovary (CHO) cells transfected with the serotonin 5-HT1A receptor have been incubated with full or partial receptor agonists and the photoreactive GTP analog, 4-azidoanilido-[alpha-32P]-GTP ([32P]-AA-GTP), to characterize the resulting receptor-G-protein interactions. Subsequent solubilization and immunoprecipitation of the membranes with anti-G(i)alpha-2 or anti-G(i)alpha-3 immunoglobulins revealed that full and partial agonists produce concentration-dependent labeling of the respective G-proteins with [32P]-AA-GTP. Full agonists of the 5-HT1A receptor [serotonin 5-hydroxytryptamine (5-HT) and 8-hydroxy-2-(di-n-propylamino)tetraline (8-OH-DPAT)] produced a 7-12-fold increase in the labeling of G(i)alpha-2 and G(i)alpha-3, whereas partial agonists (rauwolscine and ipsapirone) produced a smaller incorporation (2-5-fold) of [32P]-AA-GTP by the same G-proteins. The concentration of agonist producing half-maximal binding of [32P]-AA-GTP by G(i)alpha-3 [5-HT, 48 +/- 1 nM; 8-OH-DPAT, 28 +/- 1 nM; ipsapirone, 22 +/- 6 nM] compared to G(i)alpha-2 [5-HT, 124 +/- 38 nM; 8-OH-DPAT, 40 +/- 1 nM, ipsapirone, 82 +/- 7 nM] was lower with all agonists except rauwolscine, where the EC50's were similar (G(i)alpha-2, 604 +/- 145 nM; Gi alpha-3, 708 +/- 130 nM).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8155646     DOI: 10.1021/bi00180a024

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

Review 1.  The recombinant 5-HT1A receptor: G protein coupling and signalling pathways.

Authors:  J R Raymond; Y V Mukhin; T W Gettys; M N Garnovskaya
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

2.  Modulation of 5-HT(1A) receptor-mediated Ca(2+) responses by co-expression with various recombinant G(alpha) proteins in CHO-K1 cells.

Authors:  Thierry Wurch; Petrus J Pauwels
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-16       Impact factor: 3.000

Review 3.  The serotonin1A receptor: a representative member of the serotonin receptor family.

Authors:  Thomas J Pucadyil; Shanti Kalipatnapu; Amitabha Chattopadhyay
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

4.  5-HT receptors couple to activation of Akt, but not extracellular-regulated kinase (ERK), in cultured hippocampal neurons.

Authors:  Daniel S Cowen; Nadine N Johnson-Farley; Tatyana Travkina
Journal:  J Neurochem       Date:  2005-05       Impact factor: 5.372

5.  Activator of G protein signaling 3 null mice: I. Unexpected alterations in metabolic and cardiovascular function.

Authors:  Joe B Blumer; Kevin Lord; Thomas L Saunders; Alejandra Pacchioni; Cory Black; Eric Lazartigues; Kurt J Varner; Thomas W Gettys; Stephen M Lanier
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

6.  Differential coupling of 5-HT(1) receptors to G proteins of the G(i) family.

Authors:  Stanley L Lin; Shilpy Setya; Nadine N Johnson-Farley; Daniel S Cowen
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

7.  Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist.

Authors:  A Newman-Tancredi; J-C Martel; M-B Assié; J Buritova; E Lauressergues; C Cosi; P Heusler; L Bruins Slot; F C Colpaert; B Vacher; D Cussac
Journal:  Br J Pharmacol       Date:  2009-01-12       Impact factor: 8.739

Review 8.  Therapeutic potential of β-arrestin- and G protein-biased agonists.

Authors:  Erin J Whalen; Sudarshan Rajagopal; Robert J Lefkowitz
Journal:  Trends Mol Med       Date:  2010-12-21       Impact factor: 11.951

Review 9.  How much do we know about the coupling of G-proteins to serotonin receptors?

Authors:  Matteo Giulietti; Viviana Vivenzio; Francesco Piva; Giovanni Principato; Cesario Bellantuono; Bernardo Nardi
Journal:  Mol Brain       Date:  2014-07-10       Impact factor: 4.041

Review 10.  Update on GPCR-based targets for the development of novel antidepressants.

Authors:  Ioannis Mantas; Marcus Saarinen; Zhi-Qing David Xu; Per Svenningsson
Journal:  Mol Psychiatry       Date:  2021-02-15       Impact factor: 15.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.